MedPlus Health Services Ltd
NSE:MEDPLUS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
602.95
807.25
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MEDPLUS stock under the Base Case scenario is 839.64 INR. Compared to the current market price of 741.8 INR, MedPlus Health Services Ltd is Undervalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
MedPlus Health Services Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MEDPLUS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
MedPlus Health Services Ltd
Balance Sheet Decomposition
MedPlus Health Services Ltd
Current Assets | 15.7B |
Cash & Short-Term Investments | 1.7B |
Receivables | 175.5m |
Other Current Assets | 13.8B |
Non-Current Assets | 14.4B |
Long-Term Investments | 827.2m |
PP&E | 12B |
Intangibles | 515.3m |
Other Non-Current Assets | 1B |
Current Liabilities | 5.3B |
Accounts Payable | 2.5B |
Other Current Liabilities | 2.7B |
Non-Current Liabilities | 9B |
Long-Term Debt | 8.7B |
Other Non-Current Liabilities | 328.5m |
Earnings Waterfall
MedPlus Health Services Ltd
Revenue
|
58.3B
INR
|
Cost of Revenue
|
-45.4B
INR
|
Gross Profit
|
12.9B
INR
|
Operating Expenses
|
-11.4B
INR
|
Operating Income
|
1.4B
INR
|
Other Expenses
|
-686.2m
INR
|
Net Income
|
760.5m
INR
|
Free Cash Flow Analysis
MedPlus Health Services Ltd
INR | |
Free Cash Flow | INR |
MEDPLUS Profitability Score
Profitability Due Diligence
MedPlus Health Services Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
MedPlus Health Services Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
MEDPLUS Solvency Score
Solvency Due Diligence
MedPlus Health Services Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
MedPlus Health Services Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDPLUS Price Targets Summary
MedPlus Health Services Ltd
According to Wall Street analysts, the average 1-year price target for MEDPLUS is 943.84 INR with a low forecast of 828.2 INR and a high forecast of 1 155 INR.
Dividends
Current shareholder yield for MEDPLUS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
MEDPLUS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
MedPlus Health Services Ltd. engages in the operation of pharmacies. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-12-23. The firm operates stores in cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra. Its operations include the manufacturing and contract manufacturing of private label pharmaceutical, wellness and fast-moving consumer goods (FMCG) products, wholesale and retail sale, import, distribution, and pathology diagnostic laboratory testing. Its omni-channel platform enables it to service its customers through its stores as well as its online channels, thereby enabling it to leverage its offline channel to establish and grow its online presence. Its click and pick service allows customers to place orders directly online for collection at their preferred store. Its customers also have the option to return any items purchased through its online channel at their preferred stores.
Contact
IPO
Employees
Officers
The intrinsic value of one MEDPLUS stock under the Base Case scenario is 839.64 INR.
Compared to the current market price of 741.8 INR, MedPlus Health Services Ltd is Undervalued by 12%.